Hirano, Yutaka
Amano, Masashi
Obokata, Masaru
Izumo, Masaki
Utsunomiya, Hiroto
Article History
Received: 26 November 2023
Revised: 17 December 2023
Accepted: 4 January 2024
First Online: 15 February 2024
Declarations
:
: Dr. Izumo is a clinical proctor of Abbott Medical Japan and a screening proctor of Edwards Lifesciences. Dr. Utsunomiya is an advisor and clinical proctor of Abbott Medical Japan, and is a speaker honoraria from Bayer Yakuhin, Ono Pharmaceutical, AstraZeneca, and Bristol Myers Squibb. Dr. Obokata received research grants from Nippon Boehringer-Ingelheim and AMI Inc. and speaker honoraria from Novartis, Otsuka Pharmaceutical, Eli Lilly, AstraZeneca, and Nippon Boehringer-Ingelheim. The other authors declare that no funds, grants, or other support were received during the preparation of this manuscript.